Sponsor study identifier
interventional
148
1 country
15
Study Start
August 20, 2014
Actual (reported)Primary Completion
November 24, 2020
Actual (reported)Study Completion
November 24, 2020
Actual (reported)The purpose of this study is to evaluate bioinduction of new tissue and tendon healing after implantation of the Rotation Medical Bioinductive Implant used as either a standalone device or adjunct to surgical repair in the treatment of supraspinatus tendon tears.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 24, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 23, 2014
Actual (reported)July 25, 2014
Actual (reported)August 20, 2014
Actual (reported)November 24, 2020
Actual (reported)November 24, 2020
Actual (reported)March 2, 2022
Actual (reported)Change in Tendon Thickness
The total thickness of the tendon and any newly induced tissue at the implant site were measured at 3 months, 1 year, and 2 years using magnetic resonance imaging (MRI). Measurements were compared to pre-operative (baseline) supraspinatus tendon thickness to calculate the mean (± SD) change in post-operative supraspinatus tendon thickness by partial-thickness tear size (Intermediate or High) or full thickness tear size (Medium or Large).
Pre-operatively (baseline) to 3 month, 1 year, and 2 year
Integration of Induced Tissue With Underlying Tendon
Partial-thickness tears were classified as Intermediate (3-6 mm) or High (\> 6 mm) grade tears. Full thickness tears were categorized using Cofield classification as Medium (1-3 cm) or Large (3-5 cm). Integration and maturation of the newly induced tissue was assessed by MRI at each post-operative follow-up and determined by answering Yes, No, or Unable to determine to the following questions: 1. Is there a visible boundary between the collagen scaffold/new tissue and the supraspinatus tendon? 2. Is there visible evidence of a good margin between the collagen scaffold/new tissue and the deltoid? 3. Was there evidence of bursitis in the shoulder? 4. Does the new tissue resemble normal tendon tissue? 5. Does the underlying tendon resemble normal tendon tissue? 6. Is there any new defect (i.e., loss in supraspinatus tendon continuity; re-tear)?
3 months, 1 year, and 2 years
Fill-In of Partial Thickness Tears and Underlying Tendon Quality
For tendon defects treated by standalone use of the device (i.e., implantation without surgical repair using sutures/suture anchors), post-operative follow-up MRIs will be used to estimate the amount of defect fill-in with newly induced tissue and the quality of the filled-in tissue. In the absence of fill-in with newly induced tissue, defect progression (i.e., change in size relative to previous MRIs) will be assessed. The amount of fill-in relative to the pre-operative, baseline MRI classified as: * 0 to \<25% * 25% to \<50% * 50% to \< 75% * 75% to \< 100% * 100%
Procedure Parameters: Device Implant Time
Intraoperative
Procedure Parameters: Procedure Technical Success
Intraoperative
American Shoulder and Elbow Society (ASES) Score
Baseline, 3 month, 1 year, and 2 years
Constant-Murley Shoulder (CMS) Score
Baseline, 3 months, 1 year, and 2 years
Recovery: Sling Time
Post-operatively to study completion, approximately 2 years
Intermediate or High partial-thickness tear (PTT) or very small full-thickness tear of the supraspinatus tendon surgically treated by implantation of the bioinductive implant.
Medium or large full thickness tear (FTT) of the supraspinatus tendon surgically treated with the bioinductive implant adjunctive to surgical repair.
Surgical repair with commercially-available sutures/suture anchors.
Southern California Orthopedic Institute
Van Nuys, California, 91405, United States
Steadman Hawkins Clinic-Denver
Denver, Colorado, 80111, United States
Holy Cross Hospital Orthopedic Research Institute
Fort Lauderdale, Florida, 33334, United States
Harbin Clinic Orthopaedics & Sports Medicine Rome
Rome, Georgia, 30165, United States
OrthoIllinois, LTD
Rockford, Illinois, 61107, United States
University of Iowa Sports Medicine
Iowa City, Iowa, 52242, United States
Towson Orthopaedic Associates / University of Maryland St Joseph Med Ctr
Limitations of the study include minimal source data verification, limited safety event collection due to protocol definition, the independent Sponsor safety review occurred after data was locked and extracted from the database due to acquisition integration process.
Laura England
Smith & Nephew, Inc.
148 participants (actual enrollment reported by the registry).
First Submitted
July 23, 2014
First Posted
July 25, 2014
Study Start
August 20, 2014
Actual (reported)Bioinductive Patch for Full-Thickness Rotator Cuff Tears
3 months, 1 year, and 2 years
Number of Participants With a Re-Tear
Re-tear rate following rotator cuff repair assessed by MRI. Any new observable defect (i.e. loss in supraspinatus tendon continuity) will be classified as a re-tear.
3 months, 1 year, and 2 years
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Towson, Maryland, 21204, United States
Great Lakes Orthopaedic Center
Traverse City, Michigan, 49684, United States
Twin Cities Orthopedics
Edina, Minnesota, 55435, United States
Princeton Orthopaedic Associates, P.A.
Princeton, New Jersey, 08540, United States
OrthoCarolina Research Institute
Charlotte, North Carolina, 28207, United States
Cleveland Clinic
Cleveland, Ohio, 44125, United States
Texas Orthopedic Specialists, P.L.L.C.
Bedford, Texas, 76021, United States
Bone & Joint Clinic of Houston
Houston, Texas, 77030, United States
ProOrtho Orthopedic Clinic
Kirkland, Washington, 98034, United States
Primary Completion
November 24, 2020
Actual (reported)Study Completion
November 24, 2020
Actual (reported)Last Updated
March 2, 2022
Results First Posted
March 2, 2022
Record last verified: 2022-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: